Hillsdale Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.16M Sell
17,027
-7,700
-31% -$1.79M 0.11% 232
2025
Q4
$5.12M Sell
24,727
-1,555
-6% -$308K 0.14% 195
2025
Q3
$4.87M Sell
26,282
-18,480
-41% -$3.17M 0.15% 200
2025
Q2
$6.84M Buy
44,762
+42,570
+1,942% +$6.54M 0.25% 74
2025
Q1
$364K Sell
2,192
-1,800
-45% -$282K 0.02% 378
2024
Q4
$577K Sell
3,992
-2,000
-33% -$310K 0.03% 343
2024
Q3
$971K Sell
5,992
-609
-9% -$97K 0.07% 222
2024
Q2
$965K Buy
6,601
+3,800
+136% +$565K 0.08% 220
2024
Q1
$443K Hold
2,801
0.04% 336
2023
Q4
$439K Buy
2,801
+30
+1% +$4.6K 0.04% 331
2023
Q3
$432K Sell
2,771
-1,330
-32% -$219K 0.04% 303
2023
Q2
$679K Buy
4,101
+2,810
+218% +$454K 0.06% 199
2023
Q1
$200K Buy
1,291
+180
+16% +$29.1K 0.02% 414
2022
Q4
$196K Buy
1,111
+170
+18% +$29.4K 0.02% 406
2022
Q3
$154K Sell
941
-123
-12% -$20.8K 0.01% 398
2022
Q2
$189K Buy
1,064
+264
+33% +$47K 0.02% 400
2022
Q1
$142K Sell
800
-450
-36% -$76.6K 0.01% 415
2021
Q4
$214K Hold
1,250
0.01% 403
2021
Q3
$202K Hold
1,250
0.02% 412
2021
Q2
$206K Buy
1,250
+150
+14% +$24.8K 0.02% 408
2021
Q1
$181K Sell
1,100
-280
-20% -$45.3K 0.02% 405
2020
Q4
$217K Buy
1,380
+50
+4% +$7.38K 0.02% 386
2020
Q3
$198K Buy
1,330
+175
+15% +$25.9K 0.02% 391
2020
Q2
$163K Sell
1,155
-3,500
-75% -$510K 0.01% 397
2020
Q1
$610K Sell
4,655
-50
-1% -$7.09K 0.07% 250
2019
Q4
$686K Sell
4,705
-750
-14% -$102K 0.06% 294
2019
Q3
$706K Buy
5,455
+720
+15% +$94.9K 0.06% 277
2019
Q2
$659K Buy
4,735
+3,505
+285% +$485K 0.07% 278
2019
Q1
$172K Sell
1,230
-2,395
-66% -$321K 0.02% 388
2018
Q4
$467K Buy
3,625
+5
+0.1% +$697 0.06% 239
2018
Q3
$500K Hold
3,620
0.07% 175
2018
Q2
$438K Buy
3,620
+485
+15% +$60.5K 0.05% 210
2018
Q1
$402K Sell
3,135
-210
-6% -$28.4K 0.06% 211
2017
Q4
$467K Sell
3,345
-10
-0.3% -$1.39K 0.08% 207
2017
Q3
$437K Buy
3,355
+340
+11% +$45.1K 0.07% 203
2017
Q2
$398K Sell
3,015
-525
-15% -$67K 0.08% 198
2017
Q1
$440K Sell
3,540
-20
-0.6% -$2.39K 0.09% 178
2016
Q4
$410K Buy
3,560
+10
+0.3% +$1.16K 0.09% 181
2016
Q3
$419K Sell
3,550
-185
-5% -$22.4K 0.11% 187
2016
Q2
$454K Sell
3,735
-580
-13% -$65.9K 0.13% 110
2016
Q1
$467K Sell
4,315
-30
-0.7% -$3.11K 0.16% 89
2015
Q4
$446K Buy
4,345
+1,245
+40% +$125K 0.17% 102
2015
Q3
$289K Buy
3,100
+200
+7% +$19.3K 0.1% 219
2015
Q2
$283K Buy
2,900
+400
+16% +$40.1K 0.09% 274
2015
Q1
$252K Buy
2,500
+100
+4% +$10.2K 0.06% 321
2014
Q4
$251K Sell
2,400
-500
-17% -$52.7K 0.06% 290
2014
Q3
$309K Sell
2,900
-500
-15% -$51.9K 0.1% 180
2014
Q2
$356K Sell
3,400
-2,600
-43% -$263K 0.08% 166
2014
Q1
$589K Sell
6,000
-1,000
-14% -$92.7K 0.17% 81
2013
Q4
$641K Hold
7,000
0.19% 76
2013
Q3
$607K Buy
7,000
+1,850
+36% +$166K 0.18% 75
2013
Q2
$442K Buy
+5,150
New +$437K 0.14% 90

Other funds holding JNJ

Hillsdale Investment Management's JNJ Position: Q1 2026 in Review

Hillsdale Investment Management reduced its Johnson & Johnson (JNJ) stake by 31% in Q1 2026, selling an estimated $1.79M and leaving 17,027 shares worth $4.16M. The position accounts for 0.11% of the portfolio, ranked #232.

Hillsdale Investment Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.84M in Q2 2025. 4,619 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Hillsdale Investment Management held 17,027 shares of Johnson & Johnson worth $4.16M as of Q1 2026.
  • Hillsdale Investment Management sold 7,700 Johnson & Johnson shares in Q1 2026, an estimated $1.79M.
  • Johnson & Johnson made up 0.11% of Hillsdale Investment Management's portfolio in Q1 2026, its #232 holding.
  • Hillsdale Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Hillsdale Investment Management's Johnson & Johnson position peaked at $6.84M in Q2 2025.
  • 4,619 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.